Marshall Wace, LLP Immunocore Holdings PLC Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Marshall Wace, LLP holds 199,443 shares of IMCR stock, worth $5.64 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
199,443
Previous 248,654
19.79%
Holding current value
$5.64 Million
Previous $8.43 Million
26.32%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding IMCR
# of Institutions
141Shares Held
41.4MCall Options Held
197KPut Options Held
451K-
Wellington Management Group LLP Boston, MA7.05MShares$199 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.5MShares$184 Million0.12% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$138 Million2.42% of portfolio
-
Primecap Management CO Pasadena, CA2.47MShares$69.9 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.16MShares$61 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.24B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...